My Healthy Today

	Pelvic Artery Stent Approved

	Props open vessel that supplies blood to the legs
	FRIDAY, March 12 (HealthDay News) -- Boston Scientific's Express LD Iliac Stent has been approved by the U.S. Food and Drug Administration to treat iliac artery disease, the company said in a news release. A stent is a hollow tube that props open a blood vessel that's been blocked by a buildup of sticky plaque. In this case, the iliac arteries are located in the pelvis and supply blood to the legs. When they become clogged, it can lead to poor blood flow, leg pain and other complications. Iliac artery disease can be treated with medication, surgery or a process called angioplasty, which involves expanding a balloon-like device inside a clogged artery to improve blood flow. Installing the stent is a less invasive option than surgery, Boston Scientific said. More information The U.S. National Library of Medicine has more about this topic.


	More FDA Approvals

	• Botox Approved for Spasticity in Stroke Victims
	A common aftereffect of stroke

	• Heartburn Drug Kapidex Renamed to Dexilant
	FDA approves name change to avoid confusion with other drugs

	• Generic Flomax Approved for Enlarged Prostate
	A common condition in older men

	• Replacement Therapy Approved for Gaucher Disease
	A rare genetic disorder

Health Content Provided By:

The health content is provided for informational and educational purposes. It is intended for the general population and may not reflect specific conditions or risk of an individual or segment of the population. Therefore, it is not intended to be a substitute for professional medical advice, consultation, treatment or diagnosis. Always seek the advice of your physician or other qualified health provider with questions. Never disregard professional medical advice or delay in seeking it because of information obtained through these services.

	©2002 Private Health News. All Rights Reserved.
	©2002 Private Health News. All Rights Reserved.		Home \| E-Health Services \| Sample News \| Subscribe \| Feedback \| Contact Us Privacy Policy \| Terms & Conditions